Annual Working Capital
$309.55 M
+$261.95 M+550.29%
31 December 2023
Summary:
Spyre Therapeutics annual working capital is currently $309.55 million, with the most recent change of +$261.95 million (+550.29%) on 31 December 2023. During the last 3 years, it has risen by +$230.80 million (+293.09%). SYRE annual working capital is now at all-time high.SYRE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$363.54 M
-$50.07 M-12.11%
30 September 2024
Summary:
Spyre Therapeutics quarterly working capital is currently $363.54 million, with the most recent change of -$50.07 million (-12.11%) on 30 September 2024. Over the past year, it has increased by +$202.46 million (+125.69%). SYRE quarterly working capital is now -18.21% below its all-time high of $444.45 million, reached on 31 March 2024.SYRE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +550.3% | +125.7% |
| 3 y3 years | +293.1% | +361.7% |
| 5 y5 years | +451.3% | +547.5% |
SYRE Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +550.3% | -18.2% | +4650.9% |
| 5 y | 5 years | at high | +550.3% | -18.2% | +4650.9% |
| alltime | all time | at high | >+9999.0% | -18.2% | >+9999.0% |
Spyre Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $363.54 M(-12.1%) |
| June 2024 | - | $413.61 M(-6.9%) |
| Mar 2024 | - | $444.45 M(+43.6%) |
| Dec 2023 | $309.55 M(+550.3%) | $309.55 M(+92.2%) |
| Sept 2023 | - | $161.08 M(+2005.0%) |
| June 2023 | - | $7.65 M(-75.9%) |
| Mar 2023 | - | $31.74 M(-33.3%) |
| Dec 2022 | $47.60 M(-39.6%) | - |
| Dec 2022 | - | $47.60 M(-26.2%) |
| Sept 2022 | - | $64.54 M(-20.1%) |
| June 2022 | - | $80.78 M(+43.5%) |
| Mar 2022 | - | $56.30 M(-28.5%) |
| Dec 2021 | $78.75 M(-40.9%) | $78.75 M(-18.9%) |
| Sept 2021 | - | $97.09 M(-14.7%) |
| June 2021 | - | $113.76 M(-4.4%) |
| Mar 2021 | - | $119.04 M(-10.7%) |
| Dec 2020 | $133.35 M(+137.5%) | $133.35 M(+2.5%) |
| Sept 2020 | - | $130.05 M(-10.9%) |
| June 2020 | - | $145.98 M(+293.2%) |
| Mar 2020 | - | $37.13 M(-33.9%) |
| Dec 2019 | $56.15 M | $56.15 M(-27.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | $77.23 M(-20.3%) |
| June 2019 | - | $96.92 M(-15.7%) |
| Mar 2019 | - | $115.01 M(+73.1%) |
| Dec 2018 | $66.43 M(+34.6%) | $66.43 M(+5.7%) |
| Sept 2018 | - | $62.87 M(-13.5%) |
| June 2018 | - | $72.71 M(+68.8%) |
| Mar 2018 | - | $43.08 M(-12.7%) |
| Dec 2017 | $49.36 M(-21.0%) | $49.36 M(-9.7%) |
| Sept 2017 | - | $54.64 M(-11.6%) |
| June 2017 | - | $61.78 M(+9.6%) |
| Mar 2017 | - | $56.35 M(-9.8%) |
| Dec 2016 | $62.46 M(+74.6%) | $62.46 M(-7.9%) |
| Sept 2016 | - | $67.84 M(-7.8%) |
| June 2016 | - | $73.55 M(+134.3%) |
| Mar 2016 | - | $31.38 M(-12.2%) |
| Dec 2015 | $35.76 M(+2038.9%) | $35.76 M(-9.0%) |
| Sept 2015 | - | $39.31 M(-7.9%) |
| June 2015 | - | $42.67 M(-0.5%) |
| Mar 2015 | - | $42.91 M(+2466.2%) |
| Dec 2014 | $1.67 M(-47.5%) | $1.67 M |
| Dec 2013 | $3.19 M | - |
FAQ
- What is Spyre Therapeutics annual working capital?
- What is the all time high annual working capital for Spyre Therapeutics?
- What is Spyre Therapeutics annual working capital year-on-year change?
- What is Spyre Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly working capital year-on-year change?
What is Spyre Therapeutics annual working capital?
The current annual working capital of SYRE is $309.55 M
What is the all time high annual working capital for Spyre Therapeutics?
Spyre Therapeutics all-time high annual working capital is $309.55 M
What is Spyre Therapeutics annual working capital year-on-year change?
Over the past year, SYRE annual working capital has changed by +$261.95 M (+550.29%)
What is Spyre Therapeutics quarterly working capital?
The current quarterly working capital of SYRE is $363.54 M
What is the all time high quarterly working capital for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly working capital is $444.45 M
What is Spyre Therapeutics quarterly working capital year-on-year change?
Over the past year, SYRE quarterly working capital has changed by +$202.46 M (+125.69%)